Chandan Healthca

Who are the top shareholders of the Chandan Healthca?

The top shareholders of Chandan Healthcare include Amaranita Holdings (India) Private Limited with 16.87%, 11 Foreign Institutional Investors holding 3.86%, and Negen Undiscovered Value Fund at 3.16%. Individual investors own 33.0% of the shares, with no pledged promoter holdings or mutual fund investments.

The top shareholders of Chandan Healthcare include several key players. The majority of the shares are held by promoters, with Amaranita Holdings (India) Private Limited being the largest promoter, holding 16.87%. Additionally, there are 11 Foreign Institutional Investors (FIIs) that collectively hold 3.86% of the company's shares. The highest public shareholder is Negen Undiscovered Value Fund, which holds 3.16%. Individual investors collectively own 33.0% of the shares. Notably, there are no pledged promoter holdings and no mutual funds currently invested in the company.

When is the next results date for Chandan Healthca?

No Upcoming Board Meetings

Has Chandan Healthca declared dividend?

No Dividend History Available

Who are the peers of the Chandan Healthca?

Chandan Healthca's peers include Max Healthcare, Apollo Hospitals, Fortis Health, Narayana Hrudaya, Global Health, Asarfi Hospital, Aashka Hospitals, Aprameya Enginee, Unihealth Hosp, and Nephro Care. Key insights show excellent management and growth at several peers, with Asarfi Hospital leading in 1-year returns at 107.34%, while Chandan Healthca and Aprameya Enginee both report 0.00% returns.

Peers: The peers of Chandan Healthca are Max Healthcare, Apollo Hospitals, Fortis Health., Narayana Hrudaya, Global Health, Asarfi Hospital, Aashka Hospitals, Aprameya Enginee, Unihealth Hosp, Nephro Care.<BR><BR>Quality Snapshot: Excellent management risk is observed at Max Healthcare, Apollo Hospitals, Narayana Hrudaya, Global Health, Asarfi Hospital, Fortis Health., and Nephro Care, while Average management risk is found at Aprameya Enginee. Good growth is noted at Max Healthcare, Apollo Hospitals, Narayana Hrudaya, Fortis Health., Unihealth Hosp, and Nephro Care, while Excellent growth is seen at Chandan Healthca, Global Health, and Aprameya Enginee. Below Average growth is present at Aashka Hospitals and Asarfi Hospital, and the rest. Excellent capital structure is attributed to Max Healthcare and Global Health, while Average capital structure is found at Apollo Hospitals and Aprameya Enginee, and Good capital structure is observed at Fortis Health., Narayana Hrudaya, Asarfi Hospital, and Nephro Care, with Below Average capital structure at Aashka Hospitals, Unihealth Hosp, and the rest.<BR><BR>Return Snapshot: Asarfi Hospital has the highest 1-year return at 107.34%, while Aprameya Enginee has the lowest at 0.00%. Chandan Healthca's 1-year return is also 0.00%, which is the same as Aprameya Enginee. Additionally, Apollo Hospitals and Aashka Hospitals have negative six-month returns.

What does Chandan Healthca do?

Chandan Healthcare Ltd operates advanced laboratories offering pathological investigations and diagnostic services in the hospital sector. It is a micro-cap company with a market cap of INR 492 Cr and key metrics including a P/E ratio of 22.00 and a return on equity of 84.79%.

Overview:<BR>Chandan Healthcare Ltd operates state-of-the-art laboratories providing comprehensive pathological investigations and diagnostic services in the hospital industry, categorized as a micro-cap company.<BR><BR>History:<BR>Chandan Healthcare Ltd was established on September 03, 2003. There are no reported status changes, and revenue and profit data for the latest quarter are not available.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 492 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 22.00<BR>Industry P/E: 59<BR>Dividend Yield: 0.00%<BR>Debt-Equity: 0.49<BR>Return on Equity: 84.79%<BR>Price-to-Book: 18.87<BR><BR>Contact Details:<BR>Registrar Address: Not available.

How big is Chandan Healthca?

As of 24th July, Chandan Healthcare Ltd has a market capitalization of 583.00 Cr, classifying it as a Micro Cap company. Recent financial data, including quarterly performance, is unavailable, with the latest balance sheet from March 2022 showing Shareholder's Funds of 26.15 Cr and Total Assets of 76.12 Cr.

As of 24th July, Chandan Healthcare Ltd has a market capitalization of 583.00 Cr, categorizing it as a Micro Cap company.<BR><BR>There is no valid financial data available for the latest quarterly performance, including Net Sales and Net Profit for the latest four quarters.<BR><BR>The latest annual period for the balance sheet is March 2022, with Shareholder's Funds reported at 26.15 Cr and Total Assets at 76.12 Cr.

Is Chandan Healthca overvalued or undervalued?

As of August 28, 2025, Chandan Healthcare is considered very expensive and overvalued with a PE ratio of 24.29 and an EV to EBITDA of 13.34, especially compared to peers like Apollo Hospitals and Max Healthcare, and has recently declined by 7.9% against a 2.32% drop in the Sensex, indicating it may not be a favorable investment.

As of 28 August 2025, Chandan Healthcare's valuation grade has moved from fair to very expensive, indicating a significant shift in its market positioning. The company is currently deemed overvalued based on its financial ratios, including a PE ratio of 24.29, an EV to EBITDA of 13.34, and an ROE of 84.79%. These figures suggest that the stock is trading at a premium compared to its earnings and operational efficiency.<BR><BR>In comparison to its peers, Chandan Healthcare's valuation metrics stand out, particularly when contrasted with Apollo Hospitals, which has a PE ratio of 70.56 and an EV to EBITDA of 36.30, and Max Healthcare, which has a PE ratio of 93.61. This highlights that Chandan Healthcare is not only overvalued but also significantly more expensive relative to its competitors in the hospital industry. Furthermore, the recent stock performance shows a decline of 7.9% over the past week, while the Sensex only fell by 2.32%, reinforcing the notion that Chandan Healthcare may not be a favorable investment at its current valuation.

How has been the historical performance of Chandan Healthca?

Chandan Healthca has experienced significant growth from March 2023 to March 2025, with net sales increasing from 136.89 Cr to 230.12 Cr and profit after tax rising from 3.59 Cr to 23.52 Cr, despite facing challenges in cash flow management. Total assets grew from 76.12 Cr to 210.62 Cr, indicating a solid financial position.

Answer:<BR>Chandan Healthca has shown significant growth in its financial performance over the past three years, particularly from March 2023 to March 2025.<BR><BR>Breakdown:<BR>In terms of net sales, Chandan Healthca increased its revenue from 136.89 Cr in March 2023 to 230.12 Cr in March 2025, reflecting a strong upward trend. Total operating income followed a similar trajectory, rising from 136.89 Cr to 230.12 Cr during the same period. The company's total expenditure also grew, from 127.51 Cr in March 2023 to 188.79 Cr in March 2025, with notable increases in raw material costs and employee costs. Operating profit, excluding other income, surged from 9.38 Cr in March 2023 to 41.33 Cr in March 2025, indicating improved operational efficiency. Profit before tax rose significantly from 5.01 Cr to 32.06 Cr, and profit after tax increased from 3.59 Cr to 23.52 Cr, showcasing robust profitability growth. The earnings per share (EPS) also improved markedly from 1.69 to 9.07 over the same period. On the balance sheet, total assets grew from 76.12 Cr in March 2022 to 210.62 Cr in March 2025, while total liabilities increased from 42.05 Cr to 56.88 Cr, indicating a solid asset base. Cash flow from operating activities showed a negative trend, moving from a positive 6.00 Cr in March 2022 to a negative 29.00 Cr in March 2025, although net cash inflow remained positive at 2.00 Cr by March 2025. Overall, Chandan Healthca's performance reflects a strong growth trajectory in sales and profitability, despite challenges in cash flow management.

Why is Chandan Healthcare Ltd falling/rising?

As of 17-Mar, Chandan Healthcare Ltd's stock price is at 243.25, reflecting a decline of 1.55 or 0.63%. The stock has significantly underperformed the sector and benchmark indices, with a year-to-date drop of 25.05%, indicating a bearish trend and decreased investor confidence.

As of 17-Mar, Chandan Healthcare Ltd's stock price is falling, currently at 243.25, which reflects a decrease of 1.55 or 0.63%. The stock has underperformed compared to the sector by 1.18% today. Over the past week, the stock has declined by 4.23%, while the benchmark Sensex has only decreased by 2.80%. This trend continues over a one-month period, where the stock has fallen by 10.52% compared to an 8.34% decline in the Sensex. Year-to-date, Chandan Healthcare's stock has dropped by 25.05%, significantly more than the Sensex's 9.75% decline.<BR><BR>Additionally, the stock is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. Investor participation has also decreased, with a delivery volume of 19.2k on March 16, which is down by 71.83% against the 5-day average. This decline in trading activity suggests a lack of confidence among investors, contributing to the downward pressure on the stock price.

Why is Chandan Healthcare Ltd falling/rising?

As of 18-Mar, Chandan Healthcare Ltd's stock price is currently at 251.90, reflecting a 3.56% increase today. However, the stock has declined significantly over the past week, month, and year-to-date, indicating ongoing challenges despite the recent uptick.

As of 18-Mar, Chandan Healthcare Ltd's stock price is rising, currently at 251.90, with a change of 8.65 (3.56%) upward. This increase in price is notable as it outperformed the sector by 2.26% today. However, it is important to consider the broader context of the stock's performance. Over the past week, the stock has declined by 3.25%, and over the past month, it has fallen by 8.68%. Year-to-date, the stock is down 22.38%, which indicates a significant decline compared to the Sensex's 9.00% drop.<BR><BR>Despite the current rise, the stock is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Additionally, there has been a decrease in investor participation, with delivery volume falling by 35.32% against the 5-day average. This suggests that while there is a temporary uptick in price, the overall trend remains concerning, with declining investor interest and performance metrics indicating potential challenges ahead.

Why is Chandan Healthcare Ltd falling/rising?

As of 19-Mar, Chandan Healthcare Ltd's stock price is at 245.95, down 2.36%, with significant declines over various periods, including a year-to-date drop of 24.22%. The stock is trading below its moving averages, indicating a bearish trend, and investor interest has decreased, as shown by a 30.29% drop in delivery volume.

As of 19-Mar, Chandan Healthcare Ltd's stock price is falling, currently at 245.95, which reflects a decrease of 5.95 or 2.36%. This decline is evident in the stock's performance over various periods, where it has underperformed compared to the Sensex, showing a 1-week drop of 6.52% and a 1-month decrease of 10.20%. Year-to-date, the stock has fallen by 24.22%, significantly more than the Sensex's decline of 11.97%. <BR><BR>Additionally, the stock is trading below its moving averages across multiple time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. Investor participation has also decreased, with delivery volume on March 18 falling by 30.29% compared to the 5-day average, suggesting reduced interest from investors. Despite outperforming its sector by 0.46% today, these factors contribute to the overall downward movement in the stock price.

Why is Chandan Healthcare Ltd falling/rising?

As of 20-Mar, Chandan Healthcare Ltd's stock price is rising to 250.00, with a 1.65% increase today. However, it remains below its moving averages and has shown declines over the past week and month, indicating longer-term underperformance despite today's gains.

As of 20-Mar, Chandan Healthcare Ltd's stock price is rising, currently at 250.00, with a change of 4.05 (1.65%) increase. This upward movement can be attributed to a few key factors. Firstly, the stock has outperformed its sector by 1.09% today, indicating a stronger performance relative to its peers. Additionally, there has been a notable increase in investor participation, with a delivery volume of 28.8k on 19 March, which is up by 53.85% compared to the 5-day average. <BR><BR>However, it is important to note that despite the current rise, the stock is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a longer-term trend of underperformance. Furthermore, over the past week and month, the stock has shown declines of 0.93% and 5.21%, respectively. Year-to-date, it is down 22.97%, which contrasts sharply with its strong performance over the past year, where it has increased by 34.41%. <BR><BR>In summary, while the stock is experiencing a rise today, it is essential to consider the broader context of its recent performance and moving averages, which indicate underlying challenges.

Why is Chandan Healthcare Ltd falling/rising?

As of 23-Mar, Chandan Healthcare Ltd's stock price is at 246.00, down 1.6% and has declined 24.20% year-to-date. The stock is trading below all moving averages, indicating a bearish trend and waning investor interest.

As of 23-Mar, Chandan Healthcare Ltd's stock price is currently at 246.00, reflecting a decrease of 4.0 points or 1.6%. The stock has shown a negative performance over the past month, with a decline of 8.21%, which is significantly worse than the benchmark Sensex, which fell by 12.45% during the same period. Year-to-date, the stock has dropped by 24.20%, while the Sensex has decreased by 13.84%. <BR><BR>Despite today's performance indicating that the stock has outperformed its sector by 0.8%, it is trading below all its moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This suggests a bearish trend. Additionally, there has been a notable decline in investor participation, with the delivery volume on March 20 falling by 11.97% compared to the 5-day average. This decrease in trading activity may indicate waning investor interest, contributing to the stock's downward movement. <BR><BR>Overall, the combination of poor recent performance, lower trading volumes, and trading below moving averages suggests that Chandan Healthcare Ltd's stock price is currently falling.

Why is Chandan Healthcare Ltd falling/rising?

As of 24-Mar, Chandan Healthcare Ltd's stock price is at 241.20, down 1.95%, and underperforming the sector. The stock shows a bearish trend, trading below all key moving averages, with a year-to-date decline of 25.68%, despite increased investor participation recently.

As of 24-Mar, Chandan Healthcare Ltd's stock price is falling, currently at 241.20, reflecting a decrease of 4.8 points or 1.95%. This decline is evident in its performance today, where it underperformed the sector by 4.3%. Additionally, the stock is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend.<BR><BR>Over the past week, the stock has seen a slight decline of 0.84%, while its performance over the last month shows a more significant drop of 10.32%. Year-to-date, the stock has decreased by 25.68%, which is notably worse than the Sensex's decline of 12.31% during the same period. Despite a strong performance over the past year, where the stock rose by 32.49%, the recent trends suggest a shift in investor sentiment.<BR><BR>However, it is worth noting that there has been a rise in investor participation, with delivery volume on 23 March increasing by 200% compared to the 5-day average. This indicates some level of interest in the stock, but overall, the current indicators point to a downward movement in the stock price.

Why is Chandan Healthcare Ltd falling/rising?

As of 25-Mar, Chandan Healthcare Ltd's stock price is at 243.05, with a slight increase today but a significant decline over various periods, including a year-to-date drop of 25.11%. The stock is underperforming its sector and trading below key moving averages, indicating a bearish trend and lack of investor confidence.

As of 25-Mar, Chandan Healthcare Ltd's stock price is currently at 243.05, reflecting a change of 1.85 (0.77%) increase. Despite this slight rise today, the stock has shown a significant decline over various periods. Over the past week, it has decreased by 3.51%, and in the last month, it has fallen by 10.25%. Year-to-date, the stock is down 25.11%, which is considerably worse than the Sensex's decline of 10.80% in the same timeframe. <BR><BR>Additionally, the stock has underperformed its sector by 1.5% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Furthermore, there has been a notable drop in investor participation, with delivery volume on 24 March falling by 40% compared to the 5-day average. This decline in trading activity suggests a lack of confidence among investors, contributing to the overall negative sentiment surrounding the stock. <BR><BR>In summary, while there is a minor increase in the stock price today, the broader trend indicates a significant decline, driven by poor performance relative to benchmarks, underwhelming investor participation, and trading below key moving averages.

Which are the latest news on Chandan Healthca?